Pain assessment by patients is the rule in clinical trials but may not be in clinical practice. We examined studies comparing assessment of pain by patients and professionals in clinical practice using published studies ; $20 patients), in English, in an institutional setting, comparing pain assessment within 24 hours by patients and health care professionals. A difference of at least 10% of the maximum score was considered significant. We judged quality on sampling method, blinding, and study size. Eighty studies (20,496 patients) provided data from a range of settings and locations; most (51%) used unbiased sampling, and most (68%) were blind or probably blind. Nine studies with $500 patients involved 58% of patients; 60 with ,200 patients involved 25%. Large studies were more likely to use comprehensive or random sampling and blinding of patients and professionals. Underestimation of pain by professionals compared with patients was reported by 62/80 studies (78%); there was no difference in 17 (21%) and overestimation in 1 (1%). Underestimation was reported in 75% of large studies (.500 patients), 91% of mid-sized studies (200-400), and 78% of small studies (,200). High-quality studies (blind, comprehensive, or random sampling, .200 patients) consistently reported underestimation (10/11; 91%). The extent of underestimation tended to increase with pain severity. Professionals consistently tend to underestimate pain compared with assessment by patients. This tendency is more pronounced with more severe pain, and the extent of underestimation can be large. It is likely that this contributes to undertreatment of pain.
Introduction
The development of modern clinical analgesic research was characterised by intense scrutiny of methodology to make results reliable and free from bias. Key elements identified early were randomisation, blinding, and a minimum pain level. Because of the subjective nature of pain, another key element was that patients made their own assessment of pain intensity or relief. 3, 4, 22, 28, 38 No objective test of pain has been developed, and measurement by the patient has been the rule in clinical trials to this day; early methodological criteria have stood the test of time. 35 Why then do journals carry substantial numbers of articles (around 20 in the past 10 years) examining the question of differences in pain assessment between patients and professionals? Such studies may reflect some aspect of clinical practice such as a test of new record systems, 18 quality improvement systems, 61 or a clinical classification. 6 Anecdotally, professional rather than patient assessment of pain can seem to be the norm in everyday practice.
Professionals can have views that are very different from patients about what is important. In rheumatoid arthritis, for example, patients consider that pain is the most important symptom but rheumatologists consider the number of swollen joints to have primacy, 57 leading to significant discordance in patient and professional global assessments. 13 In advanced cancer, agreement between patient and observer ratings for various measures, including pain, was generally modest to low. 55 Patients are often not consulted over their pain, even when pain is to be expected, after surgery for example. A third of respondents to the large European PATHOS study said that pain was not assessed, and 60% had no threshold pain score above which analgesics should be given, 5 despite low pain being a driver for patient satisfaction. 37 Chronic pain is more complicated, but low pain is associated with better economic outcomes, including work. 39, 45 Even in standardised settings, pain comes at different times, at different intensities, and sometimes not at all. 34 Those experiencing moderate or severe pain consistently desire pain reduced to no pain or only mild pain and quickly. 42 Members of the general public equate moderate, and especially severe, pain with large decrements in health utility values, irrespective of their own pain status. 14 It is over 15 years since a narrative review of the agreement between patient and professional pain ratings concluded: "health professionals are not particularly accurate in their pain assessments and often tend to underestimate pain in others." 53 Pain is underestimated. 25 Why this is so is unclear. Imaging studies suggest that the human brain can detect pain intensity of others from facial expressions 51 ; empathy for pain may be underpinned
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by neural structures involved in the experience of pain. 27 Exhaustive review of factors affecting social judgement of pain describes its complexity. 58 To obtain a more complete assessment of concordance in pain rating between patients and professionals, we conducted a systematic review across all pain states, in adults able to communicate.
Methods

Searching
We searched electronic databases (MEDLINE, EMBASE, CINAHL and PsychInfo) using the terms: "Pain measurement OR (pain measurement).mp AND (agreement OR disagreement OR concordance OR discordance OR judge* OR underestimat* OR overestimat*). Searching was limited to the period 1990 to May 2016 to ensure the contemporary value of comparisons or conclusions. Electronic searches were run independently by 2 authors.
Because observational studies are difficult to identify electronically, we supplemented electronic searches with extensive eclectic searching using reference lists, review articles, and suggestive applications in PubMed and Google Scholar. 31, 50 For example, titles of studies considered possible includes were pasted into PubMed, and the lists of "Similar articles" and "Cited by PubMed articles" were examined to find whether any other articles fulfilled the inclusion criteria. The same process was followed with Google Scholar, in that case examining the citation list for the index article. For any probable include found by this method, a similar process was followed. Extensive eclectic searching was performed by all authors in different ways.
All likely articles were then discussed by all authors to choose an agreed list of included articles.
We included only English language studies because we did not have expertise to translate nuanced information. We did not consider short abstracts or unpublished studies or contact authors.
Criteria for inclusion
Included studies had to fulfil the following criteria: (1) Two authors independently reviewed the titles and abstracts to determine whether they satisfied the inclusion criteria; disagreements were resolved through discussion between all authors. Review authors were not blinded at any stage to author's names and institutions, journal of publication, or study results.
Assessment of methodological quality
We made no formal assessment of the risk of bias in studies. We anticipated that we would find mainly small observational studies that were heterogeneous in population, setting, and methods. Deeks et al. 12 considered that biases in nonrandomised studies are highly variable in causation, direction, and magnitude. They are believed to introduce additional uncertainty, rather than an estimable systematic bias. 21 Our interest was in the assessment of pain intensity by 2 or more individuals, not an intervention to change a patient's condition. We therefore considered the most important criteria to evaluate were: (1) Study recruitment. We considered that studies encompassing a whole population were less likely to be subject to any selection bias. Higher quality might then be expected from comprehensive samples or randomly selected populations than from a convenience population in which selection might have occurred. (2) Blinding. We considered blinded studies in which the 2 parties were unaware of the other's assessment to be of higher quality than unblinded studies. (3) Study size. Small studies are highly susceptible to random chance effects, 40, 43, 59 and considerable biases have been observed in small studies. 10, 11, 16, 24, 44, 49, 60 We therefore looked for agreement or disagreement in studies of more than 500 patients (large), 200 to 500 patients (moderate), or fewer than 200 patients (small size, minimum 20).
Outcome measures
We considered any attempt to provide an estimation of the level of disagreement between the patient self-reported pain and the pain recorded by the health care professional. This could be by stating the average discrepancy, reporting numbers within classes of discordance or concordance, or any appropriate statistical result. In cases in which studies reported observations of multiple episodes of pain, we used the average pain intensity or highest reported pain intensity (or the closest possible approximation to this). Our preferred measure of disagreement was for patient-professional scores to differ by at least 10% of the pain scale being used; that would be 1 cm or 10 mm on a VAS, 1 point on a 0-to 10-point NRS, 23 or the equivalent on any categorical or verbal rating scale. This "Iafrati criterion" is widely reported in studies, though it has been criticised as being somewhat arbitrary. 47 We also looked for any other measure of agreement or disagreement between the patient and health professional. For each study, all authors agreed a judgement on whether it reported evidence of underestimation, overestimation, or no difference between the patient and professional.
Data extraction and analysis
Data extracted from studies were entered into a standard form by one of 2 authors. This was then checked by another of the 2 authors, and where necessary, by a third review author. Any disagreements were resolved through discussion.
No statistical analysis was planned a priori. A descriptive analysis was considered likely to be the best approach because we expected considerable heterogeneity between studies in terms of pain condition, professionals involved, and pain assessment tools used, as well as the almost 25-year period over which they were conducted and published, together with the considerable variation in size. We used the GRADE approach to assess the quality of evidence. 20 
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Results
Description and quality of studies
Individual author searches tended to identify the same potentially relevant studies/articles. The inclusion criteria were met by 80 studies, with 20,496 patients providing relevant data ( Table 1) .
Most patients (58%) were in the 9 studies involving over 500 patients, whereas 60 studies reporting on fewer than 200 patients involved only 25% of the total. A range of different pain states was included, with acute pain, cancer pain, chronic noncancer pain, and pain in the community or nursing homes all represented. Settings for studies were diverse, involving whole hospitals or departments, or were limited to specific situations such as units for older people, critical care, burns, or nursing homes. Studies were predominantly set in Europe, the United States, Australia, or Canada (71/80 studies), but some were conducted in Israel (3), About half of the studies used comprehensive (or probably comprehensive) sampling (41%), random sampling (4%), or were analyses of randomised trials (6%); the remainder were convenience samples (38%), or there was insufficient information to make a judgement (10%). Only one of the 20 studies involving more than 200 patients used a convenience sample compared with 29/60 studies involving fewer than 200.
Most studies (68%) were blind or probably blind, meaning that neither the patient nor the professional was aware of each other's pain assessment score; the largest studies (.500 patients) were more likely to be blind (78%). Only 3 studies (4%) were explicitly not blind, and in the remainder (18%), the method of blinding was unclear or not given ( Table 1) .
Pain assessments were usually made using the standard VAS or NRS (100 mm or 10 cm) or VRS (4-point), although a few studies used nonstandard variations, such as a 15-cm VAS, a 3-or 6-point VRS, and a 21-point box scale. Some studies used more than one scale, and others converted one scale into another, for example, a VAS score into a VRS. A few studies reported only the presence or absence of pain, without any attempt to measure its intensity. Almost all of the studies involved patients with a range of pain scores, from mild pain to severe pain.
Agreement or disagreement was formally assessed in 59 studies, most frequently in larger studies; definitions of discordance used in the studies are shown in Table 2 . All definitions of disagreement were equivalent to a difference of at least 1 in 10, or 10% of the available score, and frequently higher, especially in the largest studies. Although the level of disagreement was not assessed in the remaining 21 studies, information was provided that allowed a comparison to be made on the level of discrepancy between the patient and professional, such as mean pain scores or statistical comparisons.
Degree of patient and professional agreement
Using these criteria, underestimation of pain by the professional compared with the patient was reported by 62 of the 80 studies (78% ; Table 3 ); 17 showed no difference, and in only a single study in patients with burns was there any consistent overestimation. 15 Nine studies assessed between 563 and 3575 patients each (mean study size 1325, median 869). In 7, disagreement between the patient and professional occurred in 10% to 68% of dyads, and group means disagreed by 10/100 to 30/100. Professional underestimation of pain compared with the patient was reported in 6 studies, ranging from "minor" (undefined) to 9 times more frequent underestimation than overestimation. No clear direction was apparent in 3 studies, one of which reported overestimation for incident pain and underestimation for neuropathic pain. The 4 studies that were both blinded and had comprehensive or random selection reported significant underestimation. More frequent underestimation than overestimation was reported for higher levels of pain intensity in 3 studies that specifically looked for an effect. 30, 32, 36 Eleven studies assessed 200 to 465 patients each (mean study size 308, median 252). In 6 studies, disagreement between the patient and professional occurred in 33% to 68% of dyads but another reported 65% to 80% for patients with moderate or severe pain. Another reported a mean difference between patient and professional pain scores of 29/100. Professional underestimation of pain compared with the patient was reported in 10 studies, ranging from 1.5 to 3 times greater underestimation than overestimation or "significant" or "mainly underestimation"; in 1 study, there was no clear direction. More frequent underestimation than overestimation was reported with higher pain intensity in 1 study. Six of 7 studies that were both blinded and had comprehensive or random selection reported significant underestimation.
Sixty studies assessed 20 to 198 patients each (mean study size 87, median 71). In 30 studies, disagreement between patient and professional occurred in 15% to 98% of dyads. Professional underestimation of pain compared with that of the patient was reported in 46 studies, ranging from 1.5 to 10 times greater underestimation than overestimation, or from "minor" to "major" underestimation. No direction was reported in 13 studies. One study in patients with burns reported overestimation. More frequent underestimation than overestimation was reported with higher pain intensity in 13 studies. Twenty-three of 27 studies that were both blinded and had comprehensive or random selection reported significant underestimation.
GRADE evaluation
Because of the observational design of the studies, our initial evaluation of the evidence was low quality. We uprated our assessment of quality to moderate-to-high for 4 reasons: (1) The magnitude of the degree of underestimation was large and consistent. (2) We could identify no confounding that would suggest a spurious cause for underestimation or overestimation. Table 2 Definitions of discordance. 
Discussion
This systematic review has several strengths. Studies involved different countries and a broad range of clinical conditions where pain is frequent, such as hospital settings, outpatients, primary care, and nursing homes. There was a clear and consistent message, that is, professionals frequently underestimate pain compared with the patient report. Underestimation was reported in 75% of large studies, 91% of mid-sized studies, and 78% of small studies. Underestimation was more frequent in larger of higher quality studies. Findings were consistent in different clinical settings, and despite the use of different pain scales and varying definitions of agreement or disagreement. Consistent overestimation of pain by professionals was reported in a single small study. Although there may be concerns over quality and size of the studies and the measurement and magnitude of the underestimation, the fact of generalised underestimation seems to be incontrovertible. This was especially the case with higher levels of pain intensity. Our GRADE assessment indicated the evidence to be moderate-to-high quality. Assessment of sources of bias is largely undefined for the type of studies in this review. We judged the most critical issues were sampling method, blinding of the patient and professional to the other's score, and study size. Most studies (51%) used comprehensive (or probably comprehensive) sampling, random sampling, or analyses of randomised trials; 19/20 of the largest studies used unbiased sampling. Most studies (68%) were blind or probably blind, with only 4% clearly not blind. Few studies were large, with only 9 studies (but 58% of all patients) involving over 500 patients, and 74% of patients were in the 20 studies with over 200 patients. Large studies were more likely to use comprehensive or random sampling, and blinding of the patient and professional. Large studies of the highest quality were more consistent in reporting underestimation.
A particular issue was the degree of difference required for a result to be judged a disagreement. All of the formal measures used a criterion of 10% of the value of the pain scale used (1/10 or 10/100). This is not a small difference. Farrar et al. 17 suggested that minimal clinically important differences in pain were around 33%, but that was an absolute change in an individual. Differences of 10% or above in mean pain scores between active drug and placebo are indicative of "effective" drugs because some get good pain relief but some do not, even with the best drugs. 41 Nevertheless, varying definitions of what constituted disagreement represents a weakness, although no reasonable explanation of changing definitions would affect the direction of the result. An analysis according to whether or not pain was at the acceptable level of no pain or no worse than mild pain is unlikely to have changed the findings, and may have made the comparison more stark. 42 A further weakness is the difficulty of ascertaining whether all appropriate studies have been identified. Searching for observational studies electronically has weaknesses, but we supplemented this with other methods found to be successful in similar circumstances. 31, 50 We did not have the skills adequately to translate studies in languages other than English. An updated search in PubMed to May 2017 identified one additional study that satisfied our inclusion criteria. This study supports the general findings of this review, and in particular the greater underestimation of severe pain. 52 There is a clear message that health care professionals are often poor at assessing the pain of patients for whom they care. Our findings extend those of Kappesser and Williams, 26 who reviewed 13 studies that looked at patient-observer agreement and found that professionals were more likely to underestimate patients' pain than were the patients' relatives. A systematic review of 12 studies in rheumatoid arthritis (11,879 patients) reported considerable discordance between the patient and professional rating of global assessment, with patient estimate of a worse state, driven by pain and function. 13 Children reported higher acute pain scores than those of their parents. 33 It has been argued that professionals can become "numb" to suffering. 47 Pain professionals may be better than other health care professionals in assessing patients' pain, at least in one example of paediatric intensive care nurses. 29 The reason why pain is underestimated is interesting. Patient and clinician use information largely inaccessible to the other: the patient uses his or her own beliefs about the pain and underlying causes; the clinician uses the patient's behaviour, facial expression, and information about the disorder presumed to cause the pain, and knowledge of the condition. 58 Perhaps different estimations are to be expected and may be resistant to change. Even when exposed to the patient's rating of pain after estimating it blind to that rating, clinicians do not adjust their estimates much toward the patient's rating. 48 Understanding of causation is likely to help in finding ways to overcome underestimation by professionals. 58 At present, however, the fact of significant underestimation is of primary importance. Pain assessment and report by the patient has been accepted as an absolute requirement for pain trials for over half a century. 3, 4, 22, 28, 38 A recent guideline on management of postoperative pain states "because pain is inherently subjective, patient self-report is the primary basis of all pain assessments." 7 Moreover, studies consistently demonstrate that improvements in pain therapy in hospital and especially in postoperative patients come from pain assessment by the patient, action when pain breaches a threshold, and re-evaluation of pain by the patient.
1,2,46,61 Yet painful conditions are among the most common afflicting humans worldwide, and associated with considerable numbers of years living with disability, 63 and surveys consistently show pain, including severe pain, to be a common experience even in the hospital. 19 These studies were conducted between 1991 and 2016, with no indication that the situation is improving. There will be circumstances in which patients cannot communicate their pain, but when they can, it is the patient's report that is important, as accepted for clinical trials for decades 22 and as current guidance makes clear in some institutions. 54 When professionals do not ask or believe the patient, the result is that significant pain is undertreated in a large proportion of them. 64 The practical message is to have pain measured regularly by the patient where possible, to set thresholds for action and to act on high pain scores, again as some guidance recommends. 1, 54 Because professionals can only ever estimate the patient's pain, it may not be surprising that patient and professional actual pain scores do not always agree. Professionals should therefore avoid assuming that their estimated score is accurate-the patient needs to be asked about their own pain. A concern is that health care professionals may value their own rating over that of the patient: they know the patient's rating but discount it.
Conclusions and recommendations
(1) Results of this systematic review emphasise that professionals cannot be sure of accurately assessing the pain experience of the patient before them. It is the patient's own experience that is important. In 1946, Beecher 4 described eliciting pain levels from a wounded soldier by asking the question "As you lie there are you having any pain?" This would be a good first step. (2) Patient self-assessment of pain should be the rule in clinical practice, as it is in clinical trials. (3) Other than for quality improvement purposes, 18, 61 there is no compelling reason for continuing to perform and publish studies comparing pain scoring by the patient and professional. With half a century of research consistently producing the same result, it is time to stop. Systematic research has identified similar circumstances previously. 56 (4) New research might profitably take different directions to better understand the problem of pain underestimation by professionals. These may include, but are not restricted to, investigating what impact it may have on patients and health care systems, its psychological underpinnings, the identification of its correlates, and perhaps pragmatic mechanisms to manipulate its magnitude or ameliorate its effects, for example, along the lines of providing a pain-free hospital.
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(5) Pain scoring systems are tools to help. Categorical, visual analogue, and other scoring systems are generally well correlated. 8, 9 (6) Patients with pain consider a satisfactory result to be a pain level of no worse than mild pain, achieved quickly. Patientreported pain of moderate or severe (more than 30/100 mm on a 100-mm VAS) is usually a reason to act. There is a pressing need for quality control to check that patients are asked about their pain levels and that what they themselves report is accurately recorded. That, together with examples of what can work in particular pain situations, especially in managing chronic noncancer pain, is today's research agenda. We are abundantly aware of a problem, and in many circumstances, we know the solution, but implementation is long overdue.
